Clinical significance of serum growth-regulated oncogene alpha (GROalpha) in patients with gynecological cancer.

Abstract

PURPOSE OF INVESTIGATION To assess the clinical relevance of serum growth-regulated oncogene alpha (GROalpha) levels in gynecological cancer, we investigated its concentration in distinguishing patients with cervical cancer, endometrial cancer, ovarian cancer, benign ovarian tumor and control. METHODS Preoperative serum GROalpha levels were measured in… (More)

Topics

Cite this paper

@article{Nishikawa2012ClinicalSO, title={Clinical significance of serum growth-regulated oncogene alpha (GROalpha) in patients with gynecological cancer.}, author={Robert M. Nishikawa and Nobuhiro Suzumori and T. Nishiyama and Hiroyuki Nishikawa and Akio Arakawa and Mayumi Sugiura-Ogasawara}, journal={European journal of gynaecological oncology}, year={2012}, volume={33 2}, pages={138-41} }